Continental Chemicals board to meet on May 30 for Q4FY26 results
Continental Chemicals Limited announced that its board will meet on May 30, 2026, to consider the audited financial results for the fourth quarter and fiscal year ended March 31, 2026. The agenda includes the appointment of an internal auditor for FY27. The trading window for designated persons is closed from April 1, 2026, until 48 hours post-result announcement.

*this image is generated using AI for illustrative purposes only.
Continental Chemicals Limited has scheduled a board meeting for Saturday, May 30, 2026, at its registered office in Noida. The meeting will be convened pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The primary agenda includes the consideration and approval of the audited quarterly and yearly financial results for the period ended March 31, 2026.
Agenda for the Board Meeting
The board will review the financial performance for the fourth quarter of the fiscal year 2026. Alongside the results, the directors will consider the appointment of an internal auditor for the financial year 2026-2027. The meeting may also discuss any other matters with the permission of the chair.
Trading Window Closure
In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has informed its designated persons about the closure of the trading window. This restriction is effective from April 1, 2026, and will remain in place until 48 hours after the financial results are made public to the exchanges.
Meeting Details
The board meeting is set to take place at 3:00 P.M. The venue for the meeting is the company's registered office located at A-7, Sector-7, Noida-201301 (U.P.). The intimation regarding the trading window closure has already been submitted to the stock exchanges.
Historical Stock Returns for Continental Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.00% | +15.74% | +11.44% | -8.15% | -4.89% | +385.39% |
How might Continental Chemicals Limited's FY2026 annual financial results compare to industry peers in the specialty chemicals sector, and what growth trajectory could they signal for FY2027?
What strategic priorities might the newly appointed internal auditor for FY2026-2027 focus on, given the current regulatory environment for listed chemical companies in India?
Could the board meeting's 'any other matters' agenda item potentially include announcements related to expansion plans, dividend declarations, or capital restructuring for Continental Chemicals?


































